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ramezibrahim@hotmail.comSummaryA 30-year-old female presented with a history of secondary amenorrhoea, acromegalic features and progressive visual
deterioration. She had elevated serum IGF1 levels and unsuppressed GH levels after an oral glucose tolerance test. Magnetic
resonance imaging revealed a heterogeneously enhancing space-occupying lesion with atypical extensive calcification
within the sellar and suprasellar areas. Owing to the extent of calcification, the tumour was a surgical challenge.
Postoperatively, there was clinical, radiological and biochemical evidence of residual disease, which required treatment with
a somatostatin analogue and radiotherapy. Mutational analysis of the aryl hydrocarbon receptor-interacting protein (AIP)
gene was negative. This case confirms the relatively rare occurrence of calcification within a pituitary macroadenoma and
its associated management problems. The presentation, biochemical, radiological and pathological findings are discussed
in the context of the relevant literature.Learning points:
† Calcification of pituitary tumours is relatively rare.
† Recognising calcification in pituitary adenomas on preoperative imaging is important in surgical decision-making.
† Gross total resection can be difficult to achieve in the presence of extensive calcification and dictates further
management and follow-up to achieve disease control.Background
Calcification is an uncommon feature of pituitary
adenomas and extensive calcification evident radiologi-
cally is especially rare. Between 0.2 and 14% of pituitary
adenomas display radiological evidence of calcification
(1) (2), but microscopic calcification is more common,
occurring in 5.4–25% of the cases (3) (4). Eleven cases
have been described in the literature, comprising
five patients with prolactinomas (5) (6) (7) (8) (9),three patients with growth hormone (GH)-secreting
adenomas (4) (10) (11), two patients with TSHomas (12)
and one patient with a gonadotrophin-secreting tumour
(13). It is important to recognise the presence of
calcification in pituitary adenomas, as it may influence
the choice of surgical approach (transsphenoidal vs
transcranial). Furthermore, complete resection may be
difficult, leading to the need for other treatments to
control disease activity.http://www.edmcasereports.com
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Figure 1
Preoperative T1-weighted axial (A), coronal (B) and sagittal (C) gadolinium-enhanced MRI scan.
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A 30-year-old female presented with a history of secondary
amenorrhoea and gradual onset of visual deterioration
over a period of 4 months. On review, she was found to
have prominent acromegalic features including ‘spade-
like’ hands, prognathism, increased inter-dental spacing,
skin tags, nasal enlargement, and pigmentation around
the eyes, neck and flexures. She also reported excessive
sweating and weight gain despite exercise and gave a past
history of carpal tunnel syndrome. There was no personal
or family history of prior endocrine disease.B
C
Figure 2
Axial (A), coronal (B) and sagittal (C) CT head images showing the pituitary
adenoma with suprasellar and parasellar extension and extensive
calcification (black arrows).Investigation
Formal visual field assessment revealed a bitemporal visual
field loss. Biochemical testing revealed markedly raised
insulin-like growth factor 1 (IGF1) levels (208 ng/ml;
reference range 15.3–43.1 ng/ml), suppressed gonado-
trophin levels, marginally raised prolactin (PRL) levels
(569 mU/l; reference range 50–560 mU/l) and normal
thyroid function (thyroid-stimulating hormone (TSH)
levels 1.33 mU/l and free thyroxine levels 14.9 pmol/l).
Serum calcium levels were normal (2.37 mmol/l). Cortisol
response to 250 mg of Synacthen was normal (baseline,
196 nmol/l and 30 min, 673 nmol/l). A glucose tolerance
test confirmed failure to suppress serum GH levels (nadir,
60.6 mg/l). Magnetic resonance imaging (MRI) of the
pituitary revealed a pituitary macroadenoma with sellar
and suprasellar extension (Fig. 1). The tumour was of grade
IV-D according to the modified Hardy classification.
Preoperative computed tomography (CT) of the head
confirmed a large, heavily calcified tumour in the pituitary
fossa reaching the chiasmatic cistern. The tumour
extended underneath the inferior medial aspects of both
frontal lobes and anteriorly above the planum sphenoi-
dale (Fig. 2).http://www.edmcasereports.comTreatment
The clinical, biochemical and radiological findings were
consistent with a GH-secreting pituitary macroadenoma
causing mild stalk compression hyperprolactinaemia.
Somatostatin analogue therapy (octreotide LAR 10 mg2
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Figure 3
Intraoperative image showing a dense calcified tumour dissected off the
compressed left optic nerve and chiasm.
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was scheduled for an elective craniotomy, with a view to
decompressing the optic nerves and chiasm and to reduce
the tumour bulk.
A left fronto-temporal craniotomy and a sub-frontal
approach were followed. During surgery, the tumour was
found to have a granular gritty texture with ‘stone-hard’
areas and interspersed soft tumour components. Decom-
pression of the optic nerves/chiasm was achieved, with
removal of the majority of the suprasellar tumour
component and dissection of a densely calcified part off
the left optic nerve (Fig. 3). Complete removal was not
possible due to the adherence of densely calcified tumour
to the left sellar/cavernous region and inferior medial
frontal lobes (Fig. 4).
Histology revealed heavily calcified tissue with inter-
vening sheets of mildly pleomorphic pituitary adenoma
(Fig. 5A) and reticulin network effacement but no necrosis
or significant mitotic activity (Fig. 5B). Immunohisto-
chemical staining revealed widespread GH staining
(Fig. 5C) and only minor patchy PRL staining. The tumour
did not stain for follicle-stimulating hormone, luteinizing
hormone (LH), adrenocorticotrophin or TSH. The Ki67
proliferation index was !5%, and p53 antibody staining
was negative. The overall features were consistent with a
heavily calcified GH-secreting pituitary adenoma.Figure 4
Immediate postoperative period axial CT head images showing the extent
of surgical resection with residual calcified tumour.Outcome and follow-up
Postoperatively, the patient developed transient diabetes
insipidus, which was treated with desmopressin (DDAVP).
Ophthalmological examination 1 week after surgery
revealed a marked improvement of visual acuity and visual
fields. Biochemical testing revealed normal PRL levels and
improved but non-normalised IGF1 levels (119 ng/ml) and
nadir GH levels following oral glucose administration
(7.17 mg/l). She remained euthyroid and euadrenal.http://www.edmcasereports.comFollow-up gadolinium-enhanced MRI of the head
12 weeks after surgery confirmed a reduction in the size
of the pituitary adenoma, but an enhancing residuum
was visible within the sella and overlying the planum
sphenoidale (Fig. 6).
In view of the residual disease activity and no prospect
of surgical cure by re-operation, the patient was recom-
menced on octreotide LAR therapy, titrated to a maximum
dose of 30 mg monthly. After 1 year of therapy, her IGF1
levels had improved only marginally compared with the
postoperative values (88 vs 119 ng/ml) and random GH
value was 6.02 mg/l. Furthermore, there was no reduction
in tumour volume, and hence we elected to proceed to
radiotherapy, given as conventional external beam radio-
therapy in 28 fractions. Given the patient’s young age
at presentation and resistance to somatostatin analogue
therapy, genetic analysis was carried out for mutations in
the aryl hydrocarbon receptor-interacting protein (AIP)
gene, associated with familial isolated pituitary adenomas,
but this was negative. After a further 12 months of follow-
up, serum IGF1 levels had returned to normal.Discussion
Intracranial calcification is most commonly confined to
the basal ganglia, pineal gland, falx, choroid plexus and
cerebellum. Such ‘physiological’ calcification occurs to a
limited extent, rarely attains a diameter of more than
1 cm, and has a characteristic punctate appearance.
Pathological conditions associated with intracranial calci-
fication include trauma, surgery, irradiation, hyper/
hypoparathyroidism and tumours. The differential diag-
nosis of calcified lesions in the sellar region includes
craniopharyngioma, meningioma, aneurysm, optic/
hypothalamic glioma, germ cell tumours and rarely
Rathke’s cleft cyst (14) (15). Calcification of pituitary
adenoma is relatively rare, with a reported prevalence
varying between 0.2 and 14% (1) (2).3
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Figure 5
(A) Extensive confluent calcification with small islands of intervening
tumour cells (haematoxylin and eosin (H&E) staining;!100); (B) high-
power view of tumour cells, which have mildly pleomorphic nuclei with no
significant mitotic activity or necrosis (H&E staining;!400) and (C) patchy
tumour cell GH immunoreactivity (GH antibody staining;!400).
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http://www.edmcasereports.comThe radiological appearance of calcification in pitu-
itary adenomas has been found to be either an intra-
tumoural ‘pituitary stone’ (4) (5) (7) (12) or capsular
‘egg-shell like’ (6) (13). A curvilinear pattern has been
suggested to be a feature associated with pituitary
adenomas, in contrast to the nodular pattern more
commonly observed in craniopharyngiomas (16). The
dense and extensive calcification in this case is unusual, as
it was both intratumoural and capsular.
Calcification in pituitary adenomas is postulated to be a
result of dystrophic calcification due to progressive tumour
enlargement with central ischaemic effects, which may also
promote osteoid metaplasia when well-differentiated
lamellar bone tissue is identified histologically (12) (13).
Small foci of calcification can be detected on histological
examination in 10–15% of the cases, appearing microscopi-
cally as psammoma bodies (2) (9) (17). It has also been
suggested that calcification may be induced by secondary
degenerative changes as a consequence of silent pituitary
apoplexy (8) (13). There may be intraoperative evidence of
old bleeding suggestive of prior silent apoplexy (1) (4).
Another possible explanation is induction of hetero-
topic calcification secondary to tumour compression and
increased intrasellar pressure (7) (10). The autocrine and
paracrine effects of PRL, GH and molecules such as
vascular endothelial growth factor and osteocalcin may
also promote calcification (7).
It is important to recognise the presence of calcifica-
tion within a pituitary tumour as its extent may influence
the choice of surgical approach. In previously reported
cases, surgery was carried out via a transsphenoidal route,
but these cases had a lesser extent of calcification, smaller
tumour size, and limited lateral or suprasellar extension.
In the present case, the tumour extended to the suprasellar
region, with anterior burrowing into both medial frontal
lobes above the planum sphenoidale. The extent of
calcification, appreciated better on preoperative CTA B
Figure 6
Sagittal (A) and coronal (B) T1 gadolinium-enhanced MRI postoperative
images showing enhancing residual tumour (black arrows).
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approach was carried out via a left fronto-temporal
craniotomy and a sub-frontal approach, because most of
the tumour load was on the left.
MRI was not able to verify the true extent of
calcification due to the signal dropout of calcium. It should
be emphasised that old areas of haemosiderin, which may
represent pituitary apoplexy, are also hypointense on
T1- and T2-weighted MRI sequences (2). No areas suggestive
of recent haemorrhage were encountered during surgery or
later observed during histopathological examination.
It appears that calcification can occur in any type
of pituitary hormone-producing adenoma. Intense hor-
monal activity may correlate with the development of
intratumoural calcification (5). Most reported cases are
PRL-producing adenomas due to their relatively higher
frequency (2) (17). The present case confirms the possible
occurrence of dense calcification in functioning pituitary
adenomas and highlights the importance of preoperative
imaging in evaluating such lesions before surgical resec-
tion. Gross total resection can be technically challenging
in heavily calcified large adenomas. In such cases, medical
therapy and/or radiotherapy are usually required to
achieve biochemical remission.Declaration of interest
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